Contribution statement All authors made substantial contributions to the conception and design of the trial, acquisition of data and/or the analysis and interpretation of data
Limitations of Current Human Data It's important to be transparent about what the human research does and doesn't show: Large-scale, long-term randomized controlled trials for body composition, anti-aging, and performance applications haven't been published
However, the mechanism may reasonably apply to GLP-1 therapy as well
And given the existing data of patients continuing to experience metabolic health benefits when switching from Semaglutide to Liraglutide, theres no reason to suspect the same thing wont happen with Liraglutide given it is a single-target GLP-1 receptor agonist just like Semaglutide
As a result, the liver takes up LDL from the bloodstream, lowering cholesterol levels
Nausea, jaundice, dark urine, pale stool, severe abdominal pain, confusion, swelling or rapidly worsening fatigue require medical evaluation rather than more supplements or fasting
